OMI Intrinsic Stock Value – OWENS & MINOR’s Stock Soars as Algert Global LLC Increases Holdings by 71.9%
October 10, 2024
🌥️Trending News
OWENS & MINOR ($NYSE:OMI) is a leading global healthcare services company that specializes in providing supply chain solutions for medical and surgical products. This news has caused a stir in the stock market and has resulted in a surge in OWENS & MINOR’s stock price. – Potential reasons behind Algert Global LLC’s move With their extensive experience in managing investments in the healthcare sector, Algert Global LLC may have identified potential growth opportunities and attractive valuations for OWENS & MINOR’s stock.
Additionally, the company’s recent acquisition of Halyard Health’s surgical and infection prevention business is expected to further strengthen OWENS & MINOR’s position in the market, which could have been a motivating factor for Algert Global LLC’s increased holdings. This significant increase in stock price not only highlights the confidence of investors in the company but also indicates a potential upward trend for OWENS & MINOR’s stock in the future. – Conclusion In conclusion, the recent disclosure of Algert Global LLC’s increased holdings in OWENS & MINOR has generated excitement and optimism among investors. With a strong presence in the healthcare industry and a positive outlook for future growth, OWENS & MINOR’s stock is likely to continue its upward trend. It will be interesting to see how the company utilizes this surge in stock price and leverages its new partnership with Halyard Health to further strengthen its position in the market.
Analysis – OMI Intrinsic Stock Value
After conducting an in-depth analysis of OWENS & MINOR’s wellbeing, I have determined that the company’s stock is undervalued by a significant margin. Our team at GoodWhale has utilized our proprietary Valuation Line to calculate the fair value of OWENS & MINOR’s shares, and we estimate it to be around $29.7. This means that the stock is currently being traded at a price that is 45.4% lower than its fair value. Several factors have contributed to this undervaluation of OWENS & MINOR’s stock. The company has consistently shown strong financial performance and has a solid track record of growth. Their revenue and earnings have been increasing steadily, and they have a healthy balance sheet with manageable debt. This provides a level of stability and long-term potential for the company’s growth. Despite these positive aspects, market sentiment and external factors have caused the stock to be undervalued. This presents an excellent opportunity for investors to purchase OWENS & MINOR’s shares at a discounted price. Our team at GoodWhale believes that OWENS & MINOR has significant potential for growth in the future, and the current undervaluation presents an attractive investment opportunity. We recommend keeping an eye on this stock and considering adding it to your portfolio. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for OMI. More…
| Total Revenues | Net Income | Net Margin |
| 10.33k | -41.3 | 1.0% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for OMI. More…
| Operations | Investing | Financing |
| 740.71 | -137.25 | -417.33 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for OMI. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 5.09k | 4.17k | 11.59 |
Key Ratios Snapshot
Some of the financial key ratios for OMI are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 6.8% | 8.0% | 1.0% |
| FCF Margin | ROE | ROA |
| 5.2% | 7.3% | 1.3% |
Peers
Owens & Minor Inc is in the business of distributing medical supplies and providing related services to healthcare providers. The company operates in North America and Europe. Its competitors include Orthofix Medical Inc, Medirect Latino Inc, PT Millennium Pharmacon International Tbk.
– Orthofix Medical Inc ($NASDAQ:OFIX)
Orthofix Medical Inc is a medical device company that provides orthopedic solutions to patients worldwide. The company has a market cap of 297.51M as of 2022 and a Return on Equity of -4.8%. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities. The company’s products are sold through a network of distributors and retailers.
– Medirect Latino Inc ($OTCPK:MLTO)
PT Millennium Pharmacon International Tbk is a leading pharmaceutical company in Indonesia with a market cap of 156.7B as of 2022. The company has a strong focus on research and development, and has a strong portfolio of products. The company has a Return on Equity of 17.77%.
Summary
Algert Global LLC increased its holdings in Owens & Minor, Inc. by nearly 72% during the 2nd quarter. This shows strong confidence in the company’s potential for growth and success. Investors may be drawn to Owens & Minor due to its stable financial performance and strong market position as a distributor of medical and surgical supplies.
However, they may also be keeping an eye on the company’s recent struggles with profitability and potential changes in the healthcare industry. Overall, this significant increase in holdings indicates positive sentiment towards Owens & Minor and may lead to further investment in the company.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
